RxSight Inc (RXST) with a beta value of 1.13 appears to be a promising investment opportunity.

On Tuesday, RxSight Inc (NASDAQ: RXST) opened lower -2.93% from the last session, before settling in for the closing price of $52.16. Price fluctuations for RXST have ranged from $20.66 to $66.54 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales growth of Healthcare Sector giant was 201.89%. Company’s average yearly earnings per share was noted 42.05% at the time writing. With a float of $37.63 million, this company’s outstanding shares have now reached $39.68 million.

Let’s determine the extent of company efficiency that accounts for 374 employees.

RxSight Inc (RXST) Breakdown of a Key Holders of the stock

A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of RxSight Inc is 5.17%, while institutional ownership is 78.12%. The most recent insider transaction that took place on Aug 05 ’24, was worth 353,290. Before that another transaction happened on Aug 05 ’24, when Company’s See remarks sold 9,000 for $39.25, making the entire transaction worth $353,291. This insider now owns 42,246 shares in total.

RxSight Inc (RXST) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 42.05% per share during the next fiscal year.

RxSight Inc (NASDAQ: RXST) Trading Performance Indicators

Check out the current performance indicators for RxSight Inc (RXST). In the past quarter, the stock posted a quick ratio of 13.34. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 17.44.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.01, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.53 in one year’s time.

Technical Analysis of RxSight Inc (RXST)

Looking closely at RxSight Inc (NASDAQ: RXST), its last 5-days average volume was 0.67 million, which is a jump from its year-to-date volume of 0.5 million. As of the previous 9 days, the stock’s Stochastic %D was 94.32%. Additionally, its Average True Range was 3.07.

During the past 100 days, RxSight Inc’s (RXST) raw stochastic average was set at 45.12%, which indicates a significant decrease from 86.31% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 86.93% in the past 14 days, which was higher than the 54.88% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $52.31, while its 200-day Moving Average is $47.54. However, in the short run, RxSight Inc’s stock first resistance to watch stands at $52.09. Second resistance stands at $53.55. The third major resistance level sits at $54.39. If the price goes on to break the first support level at $49.79, it is likely to go to the next support level at $48.94. Now, if the price goes above the second support level, the third support stands at $47.48.

RxSight Inc (NASDAQ: RXST) Key Stats

There are currently 36,988K shares outstanding in the company with a market cap of 2.01 billion. Presently, the company’s annual sales total 89,080 K according to its annual income of -48,610 K. Last quarter, the company’s sales amounted to 34,890 K and its income totaled -6,080 K.